• PRESS RELEASE – Constellation Kidney Group Acquires MIQS

    EMERYVILLE, CA, January 31, 2019 – The Constellation Kidney Group, an international market leader in dialysis software solutions has acquired the assets of MIQS.

    MIQS, headquartered in Boulder, CO, is a leading provider of Electronic Health Record and Billing solutions in the US and Canadian Dialysis Markets.

    “With the purchase of MIQS we continue to show our commitment to the future of end stage renal disease care around the world. We look forward to working with the MIQS team to serve their customers alongside the growing customer base of the Constellation Kidney Group” said Paul Benson, General Manager of the Constellation Kidney Group.

    “Constellation offers powerful resources to our team and our customers for long term product growth and stability.” said Mike Davis, CEO of MIQS.

    About The Constellation Kidney Group:

    The Constellation Kidney Group is part of Constellation Software Inc., an international software company traded publicly on the Toronto Stock Exchange. Constellation Software Inc., acquires, manages, and builds software businesses which provide specialized, mission-critical software solutions. The Constellation Kidney Group offers dialysis specific software solutions to healthcare providers in the US, United Kingdom, Canada, Ireland, Australia, and New Zealand. The Constellation Kidney Group includes: QMS, Infian, Clinical Computing, Mediqal H.I. and now MIQS.